Interleukin Genetics To Offer Its Innovative Inflammation Management Program To Amway Employees
July 12, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 12, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation announced today that it has...
Interleukin Genetics Reports First Quarter 2016 Financial Results
May 16, 2016 08:00 ET
|
Interleukin Genetics, Inc.
Two Agreements Year to Date to Incorporate PerioPredict® into Employee Benefit Plans Conference call today at 8:30 AM Eastern Standard time WALTHAM, Mass., May 16, 2016 (GLOBE NEWSWIRE) --...
Interleukin Genetics Announces Conference Call to Discuss First Quarter 2016 Financial Results
May 10, 2016 09:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., May 10, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Monday, May 16, 2016, at 8:30 a.m. Eastern...
Genetic Stratification of Drug Response in IL-1 Implicated Eye Diseases
May 04, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics Receives Notice of Allowance for United States Patent for PerioPredict® Genetic Risk Test
April 26, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
PerioPredict® Genetic Risk Test Incorporated into Freedom Dental Plan
April 21, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics Announces Clarification of Commercial Test Compliance
April 05, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics Announces Clinical Study to Evaluate Impact of PerioPredict® Genetic Risk Testing on Dental Patient Engagement and Preventative Care
March 29, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results
March 17, 2016 08:00 ET
|
Interleukin Genetics, Inc.
Progress in Executing Commercial Plan Underscored by Recent Agreement with Metagenics, Inc. Conference Call and Webcast Today at 8:30 a.m. EDT WALTHAM, Mass., March 17, 2016 (GLOBE...
Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation
March 16, 2016 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...